Jakop (Tofacitinib) Extended Release Tablet
Category: Pharmaceutical
Exhibitor: ORIENT PHARMA CO., LTD.
Booth No: M426
Characteristic
Tofacitinib OROS is a value-added formulation utilizing an Osmotic Controlled-Release Oral Delivery System (OROS), enabling steady, extended drug release. Bioequivalence studies demonstrated a perfect match to the reference listed drug (RLD), within the 80–125% range.
The global JAK inhibitor market was valued at USD 2.3 billion in 2023 and is projected to grow at a 22.6% CAGR, reaching USD 9.9 billion by 2030.
Tofacitinib OROS was submitted to the Taiwan FDA in December 2024 and completed the US FDA Paragraph IV non-infringement filing in February 2025.
Other Products
-
Methydur Sustained Release Capsules
-
Tonvasca Capsules 2/10 mg
-
Vancover Capsules 125 mg
-
Zulitor Tablets 4mg
-
Trokendi XR extended release capsules 25mg, 50mg, 100mg
-
Rivastigmine Patch 9.5mg/24hrs
Products you may be interested in
-
Accroma SamplePrep
-
🧬 Mycoplasma Detection Made Simple
-
Automated Pick and Collection Tool of Cell Colonies
-
Hollow Fiber Filters
-
Packaging of Pharmaceuticals and Cosmetics
-
Xcellerex™ X-platform bioreactors
-
Biacore™ 1K+ SPR system
-
Agilent Infinity III LC System
-
[Drug Formulation Development] Lipid Nano-Particles (LNP)/ Medicinal Active Molecules Encapsulation Platform
-
STUNNER - 2ul, DLS + UV/Vis combo!
-
Allogeneic CAR.BiTE γδT (CAR001) For Solid tumers
-
iQ Biosciences – Primary cells from animals
-
APNT Nanoparticle Formulation Platform
-
ALA-3000, a sustained release ketamine injectable for treatment-resistant depression
-
SuperClear Screw Cap Micro Tubes
-
Topical analgesics crafted by nature
-
General Processing Platform Isolator
-
Litesizer DLS
-
Thermo Scientific™ DynaChrom™ Single-Use Bioreactor, S.U.B.
-
ACROBiosystems CMC Residual Detection Solutions
-
EnVAX-A71
-
ADC Cytotoxic Payload Development Platform (Microbial-Derived Payloads)
-
AxiChrom™ Column
-
Diagnostic Kits And Methods Configured To Rapidly And Non-Invasively Determine Physiologic Levels Of Galactose-Deficient IgA1 (GD-IgA1) In The Subjects Of IgA Nephropathy
-
Antibody Affinity Maturation
Highest Rated Products
-
High Speed Mixing Machine
-
2ton Mixing and Melting Tank with Storage Tanks
-
Planetary Vacuum Mixer
-
Pneumatic Liquid Filling Machine
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
Powder Machine-High Speed Mixer / Granulator
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Revive Exosome Microcurrent Repair Mask
-
EnVAX-A71
-
AdimFlu-S (QIS)
-
EnVAX-A71
-
TetraFlu (Thailand)
-
AniFree Animal model nebulization system｜Nebulizer｜Inhaler
-
70+ Successful Global IND Approval
-
Packaging of Pharmaceuticals and Cosmetics
-
Pharmacovigilance
-
Methydur Sustained Release Capsules
-
ABCcolla® Collagen Bone Graft
-
JelloX Biotech Inc. -- 3D Thick Tissue Automated Staining
-
Prof. Tsai-Te Lu -- Development of Advanced Corneal Storage Media and Stem Culture Media for Optimizing Clinical Transplantation
-
Prof.Chien-Wen Jeff Chang -- Integrated Platform for Stem Cell Engineering & Matrix-Based Delivery
-
Prof. Chi-Shuo Chen -- Neubrix™ Exosome Pulmonary Precision Aerosolization Therapy
-
Fluidiconic Biotechnology -- MedSelect
-
NEBreath Vibrating Mesh Nebulizer｜Therapeutic Nebulizer｜Portable inhaler
-
BREEZONE Personalized Sub‑Health Care Solution｜Atomizer｜Aroma｜Diffuser
-
750+ Commercial Batches Manufactured
-
140+ Toxicology and Clinical Batches Manufactured
